drugset
drugset / Trial / NCT00640432

Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain

NCT00640432 ↗

Phase 4 Completed 244 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the safety and efficacy of celecoxib versus sodium diclofenac in subjects with acute low back pain

Timeline

Start
2003-10
Primary completion
—
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Comparator Diclofenac Other / unclassified 75 mg Oral

Indications

No indication recorded.